Matches in Wikidata for { <http://www.wikidata.org/entity/Q65395125> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q65395125 description "clinical trial" @default.
- Q65395125 description "ensayu clínicu" @default.
- Q65395125 description "klinisch onderzoek" @default.
- Q65395125 description "клінічне випробування" @default.
- Q65395125 name "A Study to Assess the Safety and Tolerability of N-Acetylcysteine When Administered With Pirfenidone to Participants With Idiopathic Pulmonary Fibrosis (IPF)" @default.
- Q65395125 name "A Study to Assess the Safety and Tolerability of N-Acetylcysteine When Administered With Pirfenidone to Participants With Idiopathic Pulmonary Fibrosis" @default.
- Q65395125 type Item @default.
- Q65395125 label "A Study to Assess the Safety and Tolerability of N-Acetylcysteine When Administered With Pirfenidone to Participants With Idiopathic Pulmonary Fibrosis (IPF)" @default.
- Q65395125 label "A Study to Assess the Safety and Tolerability of N-Acetylcysteine When Administered With Pirfenidone to Participants With Idiopathic Pulmonary Fibrosis" @default.
- Q65395125 prefLabel "A Study to Assess the Safety and Tolerability of N-Acetylcysteine When Administered With Pirfenidone to Participants With Idiopathic Pulmonary Fibrosis (IPF)" @default.
- Q65395125 prefLabel "A Study to Assess the Safety and Tolerability of N-Acetylcysteine When Administered With Pirfenidone to Participants With Idiopathic Pulmonary Fibrosis" @default.
- Q65395125 P1050 Q65395125-0FFBF180-AD8C-43DD-B975-F91939417B6C @default.
- Q65395125 P1050 Q65395125-8B14B822-CCAC-4642-B866-DC66C0FA62EE @default.
- Q65395125 P1132 Q65395125-0DE568D4-A814-4D5B-944D-AE097C13DFBB @default.
- Q65395125 P1476 Q65395125-091FDD04-F2A7-4601-B5E0-A8F108A428D3 @default.
- Q65395125 P17 Q65395125-113E252F-82F6-4B23-A215-454DF40FECF0 @default.
- Q65395125 P17 Q65395125-151D2499-F0A5-4B2E-B96B-C0ED5D5EB320 @default.
- Q65395125 P17 Q65395125-18D84185-EE26-4A77-AE9C-FAFB05CCC5D2 @default.
- Q65395125 P17 Q65395125-39F5F57C-91D3-4A78-AD8F-6A52B4CED508 @default.
- Q65395125 P17 Q65395125-42D07BB0-C325-41F9-AFC9-33B8388DE5A5 @default.
- Q65395125 P17 Q65395125-95080C44-A26D-4E37-8B89-35DE8FCC2CBE @default.
- Q65395125 P17 Q65395125-DA1CB1E9-E703-4B61-825A-21C3DE802CB2 @default.
- Q65395125 P17 Q65395125-DB56FF42-3237-4694-B4CC-9015F23F7033 @default.
- Q65395125 P2899 Q65395125-DC08B4BB-4A11-4D39-88A1-BE2517516EB9 @default.
- Q65395125 P3098 Q65395125-74138317-F046-48FF-A9B2-57E35EFC7393 @default.
- Q65395125 P31 Q65395125-FB7F7F31-2857-44A8-8E0A-88B170F1FF2A @default.
- Q65395125 P4135 Q65395125-03D585F0-E4B4-42DE-877A-31187230F24D @default.
- Q65395125 P580 Q65395125-6DD9A9E7-E571-43E9-9E4E-4AF6D23023CE @default.
- Q65395125 P582 Q65395125-900A9DFD-3895-4EE1-8F87-6CF4646005E9 @default.
- Q65395125 P6099 Q65395125-DF18AF50-2F9D-4D3D-A521-6A831C650E81 @default.
- Q65395125 P8363 Q65395125-76CCFDD1-F531-4582-A599-E2687725F374 @default.
- Q65395125 P859 Q65395125-DD68E251-62F1-4514-AEA7-27F4486A74F2 @default.
- Q65395125 P1050 Q2290446 @default.
- Q65395125 P1050 Q32446 @default.
- Q65395125 P1132 "+123" @default.
- Q65395125 P1476 "A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of the Safety and Tolerability of N-Acetylcysteine in Patients With Idiopathic Pulmonary Fibrosis With Background Treatment of Pirfenidone" @default.
- Q65395125 P17 Q142 @default.
- Q65395125 P17 Q145 @default.
- Q65395125 P17 Q183 @default.
- Q65395125 P17 Q31 @default.
- Q65395125 P17 Q34 @default.
- Q65395125 P17 Q35 @default.
- Q65395125 P17 Q38 @default.
- Q65395125 P17 Q40 @default.
- Q65395125 P2899 "+40" @default.
- Q65395125 P3098 "NCT02707640" @default.
- Q65395125 P31 Q30612 @default.
- Q65395125 P4135 "+80" @default.
- Q65395125 P580 "2013-08-01T00:00:00Z" @default.
- Q65395125 P582 "2015-02-01T00:00:00Z" @default.
- Q65395125 P6099 Q42824440 @default.
- Q65395125 P8363 Q78089383 @default.
- Q65395125 P859 Q212646 @default.